News

Cushing’s Patients’ Thyroid Hormone Levels Eventually Normalize Following Transsphenoidal Surgery, Study Finds

Most Cushing’s disease patients who achieve remission experience overproduction of thyroid hormones, followed by a return to normal levels,  within 12 months after surgery to remove a pituitary tumor, according to new research. The findings also showed that changes in thyroid hormones are associated with serum levels of cortisol. The research, “…

Recordati Acquires Global Rights Over Signifor and Osilodrostat

Recordati has acquired worldwide rights over Novartis‘ investigational therapy osilodrostat (LCI699), being developed for the treatment of endogenous Cushing’s disease. The agreement also covers Signifor (pasireotide), an approved treatment for adults with Cushing’s disease who failed surgery or who were not eligible for surgery,…